Dr. Eisele presents: Discovery and characterization of pathogenic transthyretin (TTR) oligomers in TTR-related amyloidosis

Published: August 10th, 2017

Category: Seminars

Date: August 24, 2017
Speaker(s): Yvonne S. Eisele, Ph.D.
Location: CTRB, 2004 Mowry Rd, Rm 3161

Please note that this seminar is located on the 3rd floor and occurs on a Thursday, instead of our regular Monday seminars.

Learning Objectives:  At the conclusion of this presentation, participants should be able to:

  1. Identify the evidence for the presence of non-native transthyretin (TTR) species in plasma of patients with TTR related amyloidosis
  2. Explain how the formation and pathogenicity of non-native TTR species can be assessed in vitro
  3. Classify structural and functional implications of non-native TTR species.

Dr. Eisele has disclosed no relevant financial relationships. No one else in a position to control content has any financial relationship(s) to disclose.

CME Information:


The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The VA designates 1.0 hour of Continuing Education credit provided for its employees.

Series #8115

 If you have any questions regarding this seminar, please contact Dr. Christy Carter at cartercs@ufl.edu